Clinical Trial Update: A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing imatinib to nilotinib in adults with newly diagnosed Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib (imatinib)
• Nilotinib (nilotinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Myelogenous Leukemia, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2013-06-17